COVID-19疫情期间SPECT心肌灌注显像异常率与疫情前比较
该单中心回顾性研究比较了COVID-19限制高峰期与2019年同期SPECT-MPI检查量及异常率。检查量从2019年每月553例降至2020年每月105例,但异常SPECT-MPI比例无差异(31% vs. 27%,p=0.4),提示即便优先安排高收益患者仍难以预测异常结果。
要点
- 疫情期间SPECT-MPI检查量从每月553例降至105例
- 异常SPECT-MPI比例2020年31% vs 2019年27%,无统计学差异
- 面诊与远程医疗评估患者的异常率无差异(28% vs 27%)
核心结论
- COVID-19限制高峰期SPECT-MPI检查量显著减少,但异常检查比例保持稳定。
- 研究提示即便提供者和负荷实验室被迫优先安排高收益患者,仍难以预测哪些患者SPECT-MPI会异常。
研究设计与样本
- 单中心回顾性研究,比较阿拉巴马大学医学中心COVID-19限制高峰期与2019年同期进行的负荷SPECT-MPI检查。
主要发现
- SPECT-MPI检查量从2019年每月553例降至2020年每月105例。
- 2020年队列(61±13岁,48%男性,41%黑人)异常SPECT-MPI比例为31%,2019年队列(62±12岁,48%男性,42%黑人)为27%,p=0.4。
- 两队列在异常心肌灌注、中-大灌注缺损、心肌缺血、心肌瘢痕及左心室射血分数异常方面的患者比例相似。
- 基于面诊或远程医疗评估的患者异常SPECT-MPI比例无差异(28% vs. 27%,p>0.9)。
- 心内科提供者转诊的患者异常SPECT-MPI比例更高(40% vs. 20%,p<0.001)。
临床怎么用
- 疫情期间SPECT-MPI检查量减少但异常率稳定,提示应维持对适宜患者的检查安排。
- 心内科提供者转诊的患者异常率更高,可考虑优化转诊路径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study is to evaluate the rate of abnormal myocardial perfusion imaging (MPI) studies at a single medical center during the COVID-19 pandemic compared to prior to the pandemic. METHODS: We retrospectively studied stress single-photon emission computed tomography (SPECT)-MPI studies performed during the peak of COVID-19 restrictions at the University of Alabama Medical Center in comparison to the same time period in 2019. RESULTS: SPECT-MPI volume was reduced from 553 per month in 2019 to 105 per month in 2020. The proportion of abnormal SPECT-MPI for the 2020 cohort (61 ± 13 years, 48% men, 41% black) was not different from the 2019 cohort (62 ± 12 years, 48% men, 42% black) (31% vs. 27%, p = 0.4). Similar proportion of patients in the 2 cohorts had abnormal myocardial perfusion, moderate-large perfusion defects, myocardial ischemia, myocardial scar, and abnormal left ventricular ejection fraction. The proportion of abnormal SPECT-MPIs was not different based on whether patients were evaluated face-to-face or by telemedicine (28% vs. 27%, p > 0.9) but was higher for cardiology providers (40% vs. 20%, p < 0.001). CONCLUSIONS: There was a significant reduction in the number of SPECT-MPI studies performed during the peak restrictions from the pandemic. Despite this restriction, the rate of abnormal studies remained stable. Our study suggests that it remains difficult to predict which patients will have abnormal SPECT-MPI even when providers and stress laboratories are forced to prioritize the performance of studies to high-yield patients.
引用
- Hasnie UA, Bhambhvani P, Iskandrian AE, et al. Prevalence of abnormal SPECT myocardial perfusion imaging during the COVID-19 pandemic. Eur J Nucl Med Mol Imaging. 2021. PMID: 33416952. doi:10.1007/s00259-020-05123-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。